With 26 new devices receiving FDA's stringent PMA approval or Humanitarian Device Exemptions (for those that treat rare diseases) so far this year, the device industry is on track to see its highest number of approvals in a decade. In 2014, there were 33 such approvals. A lowlight for the year is the lack of big VC deals. There have been no deals worth more than $60 million, compared to three that broke the $100 million mark in 2014's first half, writes EvaluateMedTech in its half-year review of the industry. More | Here's a link to the report